Chemical Works of Gedeon Richter Plc (RGEDF)
43.76
+0.45
(+1.04%)
USD |
OTCM |
Aug 25, 16:00
Chemical Works of Gedeon Richter Net Income (Quarterly) : 122.85M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 122.85M |
| March 31, 2026 | 199.45M |
| December 31, 2025 | 206.87M |
| September 30, 2025 | 128.26M |
| June 30, 2025 | 145.66M |
| March 31, 2025 | 177.19M |
| December 31, 2024 | 166.44M |
| September 30, 2024 | 103.46M |
| June 30, 2024 | 193.30M |
| March 31, 2024 | 191.60M |
| December 31, 2023 | 103.86M |
| September 30, 2023 | 155.08M |
| June 30, 2023 | 87.68M |
| March 31, 2023 | 107.97M |
| December 31, 2022 | -65.77M |
| September 30, 2022 | 205.05M |
| June 30, 2022 | 212.82M |
| March 31, 2022 | 116.65M |
| December 31, 2021 | 147.60M |
| September 30, 2021 | 128.20M |
| June 30, 2021 | 97.51M |
| March 31, 2021 | 89.88M |
| December 31, 2020 | 71.92M |
| September 30, 2020 | 76.04M |
| June 30, 2020 | 100.73M |
| Date | Value |
|---|---|
| March 31, 2020 | 94.48M |
| December 31, 2019 | -45.42M |
| September 30, 2019 | 76.14M |
| June 30, 2019 | 62.40M |
| March 31, 2019 | 77.26M |
| December 31, 2018 | -56.71M |
| September 30, 2018 | 32.58M |
| June 30, 2018 | 92.74M |
| March 31, 2018 | 56.24M |
| December 31, 2017 | 27.59M |
| September 30, 2017 | 61.36M |
| June 30, 2017 | 31.83M |
| March 31, 2017 | 71.76M |
| December 31, 2016 | 79.40M |
| September 30, 2016 | 52.10M |
| June 30, 2016 | 62.71M |
| March 31, 2016 | 41.56M |
| December 31, 2015 | 36.46M |
| September 30, 2015 | 24.04M |
| June 30, 2015 | 80.88M |
| March 31, 2015 | 54.66M |
| December 31, 2014 | -16.63M |
| September 30, 2014 | 24.14M |
| June 30, 2014 | 61.45M |
| March 31, 2014 | 41.92M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| AstraZeneca PLC | 3.076B |
| ANI Pharmaceuticals, Inc. | 23.00M |
| Corcept Therapeutics, Inc. | 42.14M |
| Veru, Inc. | -6.988M |
| Avadel Pharmaceuticals Plc | 0.02M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 777.18M |
| Total Expenses (Quarterly) | 653.98M |
| EPS Diluted (Quarterly) | 0.6729 |
| Enterprise Value | 7.165B |
| Gross Profit Margin (Quarterly) | 70.03% |
| Profit Margin (Quarterly) | 15.81% |
| Earnings Yield | 8.23% |
| Operating Earnings Yield | 12.53% |
| Normalized Earnings Yield | 8.226 |